Autoimmunity BioSolutions
Last verified 2026-05-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.2Mattributed |
|---|---|
| Latest round | Funding round, $3.2M, 2026-05-06attributed |
| Founded | unknown |
| Headquarters | Houston, TX |
| Industry | biotechnology |
| Stage | unknown |
| Website | abstherapeutics.com |
Seed-stage biotech developing a next-generation, immuno-corrective antibody therapy to restore normal immune function in autoimmune diseases.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-06 | Funding round | $3.2M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Envoy, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $3.2M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $3.2M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | abstherapeutics.com, read 2026-05-13 |
| Description | self-reported | abstherapeutics.com, read 2026-05-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $3.2M, 2026-05-06 → Funding round, $3.2M, 2026-05-06, sec-edgar, No document URL on file | Latest round | seed, $3.2M, 2026-05-06 → Funding round, $3.2M, 2026-05-06 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes